Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim and Sutter Health, a US-based not-for-profit health system, have entered into a five-year research and health care innovation collaboration.
Subscribe to our email newsletter
Under the deal, the parties will explore and test the value of digital health solutions, mobile technologies and insights from advanced data analytics in the delivery of health care.
The deal will bring together Boehringer’s research and development expertise in new medications to address unmet therapeutic needs with Sutter Health’s research and clinical experience from caring for a diverse population of more than 3 million patients in its network of hospitals and healthcare providers.
Initially, the collaboration will focus on chronic lower respiratory diseases including chronic obstructive pulmonary disease (COPD).
Sutter Health chief research officer Walter Stewart said: "Ultimately, we all want to help patients reduce COPD symptoms and live healthier lives.
"We believe that innovative technologies can help us develop a deeper understanding of patient needs, values, and care preferences — and create more time during office visits for doctors and patients to partner toward improved health outcomes."
The initial collaboration will see development of a reliable, electronic (tablet or kiosk-based) data collection system to collect information directly from the patient, during every health encounter.
The companies also aim to make it easier for healthcare professionals and patients to communicate about treatment options by developing technological means for integrating clinical and patient reported data in an engaging visual display.